Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Biocept Inc
(NQ:
BIOC
)
4.410
USD
+0.130 (+3.04%)
Official Closing Price
Updated: 7:59 PM EDT, Apr 13, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Biocept Inc
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
April 08, 2021
Gainers DiaMedica Therapeutics (NASDAQ:DMAC) shares increased by 6.17% to $9.98 during Thursday's after-market session. DiaMedica ...
Tags
KURA
BIOC
ECOR
From
Benzinga
Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System
April 07, 2021
Biocept, Inc. (Nasdaq: BIOC) will host a webinar featuring leading neuro-oncologists to discuss the use of the Company’s proprietary cerebrospinal fluid (CSF) assay for diagnosing and managing tumors...
From
Business Wire News Releases
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2021
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040...
From
Business Wire News Releases
Proactive news headlines including Milestone Scientific, Nextleaf Solutions, Nano One Materials and Delta 9 Cannabis Inc
April 01, 2021
Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:
From
GlobeNewswire News Releases
Biocept to Host Key Opinion Leader Webinar on April 8 to Discuss its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System
April 01, 2021
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, will host a webinar featuring leading neuro-oncologists to discuss the use of the Company’s...
From
Business Wire News Releases
41 Stocks Moving In Tuesday's Mid-Day Session
March 30, 2021
Gainers VirTra, Inc. (NASDAQ: VTSI) shares jumped 53.6% to $7.34 after the company reported better-than-expected Q4 ...
Tags
MEDS
ORPH
Benzinga
From
Benzinga
Thinking about buying stock in Biocept, AbCellera Biologics, Novan, Seelos Therapeutics, or SRAX?
March 30, 2021
InvestorsObserver issues critical PriceWatch Alerts for BIOC, ABCL, NOVN, SEEL, and SRAX.
From
PR Newswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 30, 2021
Gainers Monopar Therapeutics (NASDAQ:MNPR) stock rose 20.83% to $6.96 during Tuesday's pre-market session. The ...
Tags
BIOC
XBIO
ORGO
From
Benzinga
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
March 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ONCR
ADAG
PIRS
From
Benzinga
33 Stocks Moving in Tuesday's Pre-Market Session
March 30, 2021
Gainers VirTra, Inc. (NASDAQ: VTSI) rose 125.5% to $10.78 in pre-market trading after the company reported better-than-expected Q4 ...
Tags
MOVE
ACY
WAFU
From
Benzinga
A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, House Price Data
March 30, 2021
Pre-open movers U.S. stock futures traded mixed in early pre-market trade as the Wall Street closed mixed in the previous session ...
Tags
A Peek Into The Markets
MKC
News
From
Benzinga
5 Stocks To Watch For March 30, 2021
March 30, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects McCormick & Company, Incorporated (NYSE: MKC) ...
Tags
Earnings
Market News
Pre/Market Outlook
From
Benzinga
8 Stocks Moving In Monday's After-Hours Session
March 29, 2021
Gainers SRAX (NASDAQ: SRAX) shares are trading higher after the company reported Q4 earnings results, issued Q2 sales guidance and ...
Tags
News
BIOC
MEDS
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 29, 2021
Gainers Biocept (NASDAQ:BIOC) stock moved upwards by 36.69% to $7.04 during Monday's after-market session. At the close, ...
Tags
BIOC
SCPH
General
From
Benzinga
Biocept: Q4 Earnings Insights
March 29, 2021
Shares of Biocept (NASDAQ:BIOC) moved higherin after-market trading after the company reported Q4 results. Quarterly ...
Tags
Market News
Earnings
Benzinga
From
Benzinga
Biocept Reports 2020 Fourth Quarter and Full Year Financial Results
March 29, 2021
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and 12 months ended December 31, 2020 and provides a...
From
Business Wire News Releases
Earnings Scheduled For March 29, 2021
March 29, 2021
Companies Reporting Before The Bell • Acacia Research (NASDAQ:ACTG) is likely to report earnings for its fourth ...
Tags
News
BIOC
GOED
From
Benzinga
The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
March 27, 2021
Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broader market weakness. The ...
Tags
Benzinga
DARE
AZRX
From
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 26, 2021
Gainers 180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 48.04% to $8.69 during Friday's pre-market session. ...
Tags
OTLK
ATNF
Top Gainers
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 24, 2021
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 39.95% to $6.34 during Wednesday's pre-market session. The ...
Tags
IRIX
Markets
BCLI
From
Benzinga
Biocept to Report 2020 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 29, 2021
March 22, 2021
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that it will release financial results for the three and 12 months ended December 31,...
From
Business Wire News Releases
3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy
March 16, 2021
Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc(NASDAQ:GNMK) in a $1.8 billion dealon Monday, the same ...
Tags
Biotech
Penny Stocks
VCYT
From
Benzinga
Biocept to Participate in Three Virtual Investment Conferences in March
March 09, 2021
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that President and CEO Michael Nall will participate in three upcoming virtual...
From
Business Wire News Releases
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 03, 2021
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 38,250...
From
Business Wire News Releases
Proactive news headlines including Energy Fuels, Tartisan Nickel Corp, Medexus Pharmaceuticals and Falcon Gold
March 02, 2021
Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:
From
GlobeNewswire News Releases
Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load
March 02, 2021
COVID-19 test, based on Aegea's next-generation COVID-19 assay kit using Switch-Blocker[™] technology, may provide answers that support screening and managing patients
From
PR Newswire
Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load
March 02, 2021
Aegea Biotechnologies & Biocept enter supply agreement to validate and commercialize new COVID-19 test to help screen, manage, and evaluate patients.
From
Business Wire News Releases
Biocept Inks Research Pact With Protean BioDiagnostics For Target Selector Kit Advantages In Lung Cancer
February 23, 2021
Biocept Inc(NASDAQ:BIOC)will collaborate withProtean BioDiagnostics Incto research Biocept's Target ...
Tags
Market News
lung cancer
Benzinga
From
Benzinga
Biocept and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept’s Target Selector™ Assay Kit for Non-Small Cell Lung Cancer Patients
February 23, 2021
Biocept and Protean BioDiagnostics Collaborate to Demonstrate Advantages of Biocept’s Target Selector Assay for Non-Small Cell Lung Cancer Patients.
From
Business Wire News Releases
Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients
February 16, 2021
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, will present data showing that its Target Selector™ molecular assay kit detects mutations in up...
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.